Detailansicht

Wissensnetz

Person

Kristian Wilfried Pajtler (1980-)

Arzt

Name	Kristian Wilfried Pajtler
Zeit	1980- (Lebensdaten)
Ort	Deutschland
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Variante	Kristian W. Pajtler K. W. Pajtler
Weitere Angaben	Department of Pediatric Oncology, Hematology and Immunology University Hospital Heidelberg Germany
Datensatztyp	Person
GND-Nummer	1012877264
Datensatz-ID	1012877264
Beteiligt an alle anzeigen Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage Developmental basis of SHH medulloblastoma heterogeneity Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting Adult Medulloblastoma : Updates on Current Management and Future Perspectives PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome Genotype–phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE host genome working group Development of randomized trials in adults with medulloblastoma - the example of EORTC 1634-BTG/NOA-23 Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies YAP1-fusions in pediatric NF2-wildtype meningioma YAP1-fusions in pediatric NF2-wildtype meningioma Ein Update zum Li-Fraumeni-Syndrom MYCN amplification drives an aggressive form of spinal ependymoma Heterogeneity within the PF-EPN-B ependymoma subgroup FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas Author Correction: The landscape of genomic alterations across childhood cancers Ependymoma The landscape of genomic alterations across childhood cancers Genetic confirmation that ependymoma can arise as part of multiple endocrine neoplasia type 1 (MEN1) syndrome The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors Analyse der Interaktion Trk-Rezeptor tragender Neuroblastomzellen mit Zellen des Immunsystems und mit Schwannzellen

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Kristian Wilfried Pajtler (1980-)

Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage

Developmental basis of SHH medulloblastoma heterogeneity

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort

Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting

Adult Medulloblastoma : Updates on Current Management and Future Perspectives

PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas

Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome

Genotype–phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry

Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas

Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors

Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group

Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE host genome working group

Development of randomized trials in adults with medulloblastoma - the example of EORTC 1634-BTG/NOA-23

Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors

The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

YAP1-fusions in pediatric NF2-wildtype meningioma

YAP1-fusions in pediatric NF2-wildtype meningioma

Ein Update zum Li-Fraumeni-Syndrom

MYCN amplification drives an aggressive form of spinal ependymoma

Heterogeneity within the PF-EPN-B ependymoma subgroup

FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma

Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas

Author Correction: The landscape of genomic alterations across childhood cancers

Ependymoma

The landscape of genomic alterations across childhood cancers

Genetic confirmation that ependymoma can arise as part of multiple endocrine neoplasia type 1 (MEN1) syndrome

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants

Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors

Analyse der Interaktion Trk-Rezeptor tragender Neuroblastomzellen mit Zellen des Immunsystems und mit Schwannzellen